๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Continuous-infusion vinblastine in refractory carcinoma of the cervix: A phase II trial

โœ Scribed by John J. Kavanagh; Larry J. Copeland; David M. Gershenson; Patton B. Saul; J.Taylor Wharton; Felix N. Rutledge

Book ID
119052565
Publisher
Elsevier Science
Year
1985
Tongue
English
Weight
264 KB
Volume
21
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Phase II trial of vinblastine in advance
Phase II trial of vinblastine in advanced ovarian carcinoma
โœ Gregory P. Sutton; John A. Blessing; Mark D. Adelson; Parviz Hanjani ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› Springer US ๐ŸŒ English โš– 231 KB

A phase II trial of vinblastine in patients with refractory epithelial ovarian adenocarcinoma of the ovary was conducted by the Gynecologic Oncology Group (GOG) between March 9, 1988 and July 7, 1988. Vinblastine was administered in a dose of 9 mg/m2 intravenously every three weeks until disease pro

A Phase II trial of methotrexate, vinbla
A Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix
โœ Christos A. Papadimitriou; Meletios A. Dimopoulos; Nikolaos Giannakoulis; Kyrill ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB ๐Ÿ‘ 3 views

## Background: Patients with metastatic carcinoma of the uterine cervix have limited survival. thus, new chemotherapeutic agents and combinations are needed to improve patient outcome. ## Methods: Twenty-seven patients with stage iv primary or recurrent carcinoma of the uterine cervix were assign